MARCH4 Inhibitors
Items 1 to 10 of 19 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin inhibits MARCH by blocking HMG-CoA reductase, a key enzyme in cholesterol synthesis, leading to reduced cholesterol levels in cells. Lower cholesterol levels decrease MARCH activation. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin, like simvastatin, inhibits HMG-CoA reductase, reducing cellular cholesterol levels and indirectly inhibiting MARCH activation. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Atorvastatin inhibits HMG-CoA reductase, reducing cholesterol production and subsequently inhibiting MARCH activation. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $145.00 | 8 | |
Rosuvastatin inhibits HMG-CoA reductase, leading to decreased cholesterol synthesis and potential inhibition of MARCH. | ||||||
Cerivastatin, Sodium Salt | 143201-11-0 | sc-207418 | 2.5 mg | $179.00 | ||
Cerivastatin inhibits HMG-CoA reductase, resulting in decreased cholesterol production, which may impact MARCH activation. | ||||||
Pitavastatin Calcium | 147526-32-7 | sc-208176 sc-208176A | 10 mg 25 mg | $114.00 $175.00 | 8 | |
Pitavastatin inhibits HMG-CoA reductase, lowering cellular cholesterol levels, which can indirectly affect MARCH activity. | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
Fluvastatin sodium, a salt form of fluvastatin, inhibits HMG-CoA reductase, potentially influencing MARCH through cholesterol reduction. | ||||||
Rosuvastatin Calcium Salt | 147098-20-2 | sc-208316 | 10 mg | $210.00 | 5 | |
Rosuvastatin calcium inhibits HMG-CoA reductase, reducing cholesterol synthesis and potentially impacting MARCH activation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor, potentially impacting ubiquitin-proteasome pathways relevant to MARCH. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Another proteasome inhibitor, might indirectly affect MARCH activity. | ||||||